DavidWHaasMD
Infectious Disease • Nashville, TNProfessor, Medicine, Vanderbilt University School of Medicine
Dr. Haas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 1987 - 1988- Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1987
Vanderbilt University School of MedicineClass of 1983
Certifications & Licensure
TN State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body
- Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Start of enrollment: 2014 Jan 01
- Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery Start of enrollment: 2014 Jul 02
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsHLA tapasin independence: broader peptide repertoire and HIV control.Arman Bashirova, Mathias Viard, Vivek Naranbhai, Alba Grifoni, Wilfredo F. Garcia-Beltran
Proceedings of the National Academy of Sciences of the United States of America. 2020-11-10 - 1204 citationsDefining the role of common variation in the genomic and biological architecture of adult human heightAndrew R. Wood, Tõnu Esko, Jian Yang, Sailaja Vedantam, Tune H. Pers
Nature Genetics. 2014-11-01 - 179 citationsExtremely low-coverage sequencing and imputation increases power for genome-wide association studiesBogdan Pasaniuc, Nadin Rohland, Paul J. McLaren, Kiran V. Garimella, Noah Zaitlen
Nature Genetics. 2012-06-01
Press Mentions
Vanderbilt University Medical Center Seeks COVID-19 Patients for Participation in ACTIV-2 TrialApril 13th, 2021- Vanderbilt Seeks Volunteers for Clinical Trial to Find COVID-19 TreatmentsApril 12th, 2021
- Vanderbilt Seeks Volunteers for COVID-19 Clinical TrialApril 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
